Barbara Dapas

Trieste, 34149, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Correction: Tonon et al. 5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway. Cancers 2022, 14, 1630.

Correction: Tonon et al. 5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway. Cancers 2022, 14, 1630.

Journal: Cancers

Published: February 27, 2026

Non-Coding RNAs as Potential Diagnostic/Prognostic Markers for Hepatocellular Carcinoma.

Non-Coding RNAs as Potential Diagnostic/Prognostic Markers for Hepatocellular Carcinoma.

Journal: International journal of molecular sciences

Published: October 05, 2024

In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells.

In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells.

Journal: Pharmaceutics

Published: April 12, 2024

Plasma Circular RNAs as Biomarkers for Breast Cancer.

Plasma Circular RNAs as Biomarkers for Breast Cancer.

Journal: Biomedicines

Published: March 07, 2024

Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases.

Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases.

Journal: International journal of molecular sciences

Published: December 31, 2023

Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches.

Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches.

Journal: Pharmaceutics

Published: March 19, 2023

Nanomechanical Characterization of Ovarian Cancer Cell Lines as a Marker of Response to 2c Treatment.

Nanomechanical Characterization of Ovarian Cancer Cell Lines as a Marker of Response to 2c Treatment.

Journal: International journal of molecular sciences

Published: March 16, 2023

High eEF1A1 Protein Levels Mark Aggressive Prostate Cancers and the In Vitro Targeting of eEF1A1 Reveals the eEF1A1-actin Complex as a New Potential Target for Therapy.

High eEF1A1 Protein Levels Mark Aggressive Prostate Cancers and the In Vitro Targeting of eEF1A1 Reveals the eEF1A1-actin Complex as a New Potential Target for Therapy.

Journal: International journal of molecular sciences

Published: February 28, 2022

Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach.

Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach.

Journal: Drug delivery and translational research

Published: February 04, 2022

An Overview of siRNA Delivery Strategies for Urological Cancers.

An Overview of siRNA Delivery Strategies for Urological Cancers.

Journal: Pharmaceutics

Published: February 03, 2022

5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway.

5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway.

Journal: Cancers

Published: December 30, 2021

Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules.

Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 15, 2021

Showing 1-12 of 45

Last Updated: 09/26/2026